Johnson & Johnson (NYSE:JNJ) Given Buy Rating at Guggenheim
Johnson & Johnson (NYSE:JNJ) Given Buy Rating at Guggenheim MarketBeat
Covered in this story
What has happened since
- Johnson & Johnson is up 0.3% since this was published, 80 days ago.
Price move measured from the close nearest publication to the latest quote.
Tracked from this story
Guggenheim’s $270 target on $JNJ is on the record and being tracked to Jul 2027 (12-month default), scored on the close that day.
Guggenheim’s track record →Analyst targets on Johnson & Johnson
- Bank of America: $265 → $278 by Sep 2027 · Neutral via AOL.com
- Raymond James: $254 → $280 by Aug 2027 · Outperform via Investing.com
- Wells Fargo: $254 → $282 by Aug 2027 · Overweight via GuruFocus
Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.
Call it yourself
No member calls on $JNJ yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Johnson & Johnson →Dalsna Finance is currently tracking 43 stories mentioning Johnson & Johnson, the earliest published 11 Jun 2026.
Summary aggregated from MarketBeat's public RSS feed. The full reporting belongs to MarketBeat — please read it on their site.